Medivation, Astellas launch Xtandi capsules
Xtandi, an oral, once-daily androgen receptor inhibitor approved by the FDA, is being distributed through a network of specialty pharmacies and specialty distributors. Medivation co-founder, president and chief
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.